PMI Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -26.16%, SMA50 -35.11%, SMA200 -72.53%). The stock’s 14-day RSI is 30.23 (weak momentum), while the ATR of 0.2 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -91.59% below its high and over 1.77% above its low. Average 10-day trading volume of 52.79 thousand shares is below the 3-month average of 434.25 thousand, indicating normal recent market interest.

Picard Medical, Inc. earnings surprise history is a mixed track record. The quarter that ended August 19, 2026, missed forecasts by -11.33%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in May 15, 2026.

Picard Medical, Inc. has 102.70 million shares outstanding. The public float is 39.51 million shares, elevated short interest at 24.41% of float. This equals 15.40 million shares. The short ratio is 0.53 days. Institutional investors hold 13.81% of the float. Insiders own 47.67%.

currently trading near 52-week highs band. Valuation shows Picard Medical, Inc. trading at a premium to the broader market with a P/E of -0.15. Our AI forecast model points to short-term weakness (-52.89% over two weeks), a medium-term fall (-96.96% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Picard Medical, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.41. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Picard Medical, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -52.89%, with price expected at $1.55 by September 02, 2026, within a range of $0.69 to $2.37 3-Month Outlook: Projected fall of -96.96%, reaching $0.10 by November 17, 2026, with a range of $0.00 to $7.38. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by August 19, 2027, within a range of $0.00 to $9.45.

Picard Medical, Inc. (AMEX:PMI) closed at $3.03 USD, losing -$0.26 (-8.05%) from the previous close of $3.29. The stock is currently trading near its 52-week low $3.00 and $684.00. With a market capitalization of about $310.68 million, Picard Medical, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~-2.64). Key stats such as the average daily volume over the past year has been around 663.06 thousand shares, volume is running light vs its 52-week average. Headquartered in Tucson, AZ, Picard Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Richard Fang, the company employs approximately 75 people and listed since August 29, 2025. Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales.

Picard Medical, Inc. trades at a P/E ratio of -0.15, slightly below the S&P 500 average, with a price-to-sales ratio of 60.94 and a price-to-book ratio of -3.34 indicating negative book value, which may reflect financial stress. The P/FCF stands at -19.34, also below market averages.